Home/Filings/4/0001127602-14-003262
4//SEC Filing

VIROPHARMA INC 4

Accession 0001127602-14-003262

CIK 0000946840operating

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 9:16 PM ET

Size

17.7 KB

Accession

0001127602-14-003262

Insider Transaction Report

Form 4
Period: 2014-01-24
Transactions
  • Disposition to Issuer

    Non-qualified Stock Option (Right to Buy)

    2014-01-2410,0000 total
    Exercise: $20.15From: 2007-02-20Exp: 2016-02-19Common Stock (10,000 underlying)
  • Disposition to Issuer

    Non-qualified Stock Option (Right to Buy)

    2014-01-2415,0000 total
    Exercise: $31.74From: 2013-02-24Exp: 2022-02-24Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2014-01-2415,0000 total
    Exercise: $17.30From: 2012-02-21Exp: 2021-02-21Common Stock (15,000 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2014-01-244,5000 total
    Common Stock (4,500 underlying)
  • Disposition to Issuer

    Non-qualified Stock Option (Right to Buy)

    2014-01-2410,0000 total
    Exercise: $17.76From: 2008-02-26Exp: 2017-02-25Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2014-01-2415,0000 total
    Exercise: $25.25From: 2014-02-22Exp: 2023-02-22Common Stock (15,000 underlying)
  • Disposition from Tender

    Common Stock

    2014-01-24$50.00/sh49,000$2,450,0000 total
Footnotes (4)
  • [F1]The options vest in full one year from date of grant.
  • [F2]This derivative security, regardless of whether otherwise previously vested, was canceled in connection with the merger of ViroPharma Incorporated with and into Shire Pharmaceutical Holdings Ireland Limited, effective as of January 24, 2014 in exchange for a cash payment representing, in the case of stock options, the difference between the per-share exercise price of the stock option and $50, and in the case of restricted stock units, $50 per share.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of VPHM common stock.
  • [F4]The restricted stock unit vests in full one year from the date of grant. Vested shares will be delivered to the reporting person upon vesting.

Issuer

VIROPHARMA INC

CIK 0000946840

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000946840

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:16 PM ET
Size
17.7 KB